Pre-Existing Conditions

A pre-existing condition in insurance refers to any medical condition, injury, or illness that a person has before they enroll in a health insurance plan. Pre-existing conditions can range from chronic conditions such as diabetes, asthma, or heart disease, to more acute conditions such as a recent surgery or injury.

In the past, insurance companies could exclude coverage for pre-existing conditions or charge higher premiums for individuals with such conditions. However, under the Affordable Care Act (ACA), insurance companies are prohibited from denying coverage or charging higher premiums based on pre-existing conditions. This means that insurance plans must cover treatment for pre-existing conditions, and insurers cannot charge individuals more for their insurance coverage due to a pre-existing condition.

Here are some key features of pre-existing conditions in insurance:

• Pre-existing conditions are medical conditions that existed prior to the start of a health insurance policy.

• The Affordable Care Act (ACA) prohibits insurance companies from denying coverage or charging higher premiums based on pre-existing conditions.

• Insurance plans must cover treatment for pre-existing conditions, and insurers cannot charge individuals more for their insurance coverage due to a pre-existing condition.

• The ACA also requires all health insurance plans to cover certain essential health benefits, including treatment for pre-existing conditions.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.